Abstract Details
|
Nomin Enkhtsetseg
PRESENTER |
Ms. Enkhtsetseg has nothing to disclose. |
| Maya Mastick | Ms. Mastick has nothing to disclose. |
| Joseph Sadok | Mr. Sadok has nothing to disclose. |
| Matheus M. Mochetti | Mr. Mochetti has nothing to disclose. |
| Annabel Sorby-Adams (Massachusetts General Hospital and Harvard Medical School) | Annabel Sorby-Adams has nothing to disclose. |
| Lixin Guo | Prof. Guo has nothing to disclose. |
| Cristina Trapaga Hacker | Miss Trapaga Hacker has nothing to disclose. |
| Isabella Gomez Hjerthen | No disclosure on file |
| Seungwon Lee, BA | Miss Lee has nothing to disclose. |
| Siddharth Satish, Student | Mr. Satish has nothing to disclose. |
| Andrew Siyoon Ham | Andrew Siyoon Ham has nothing to disclose. |
| Justin B. Hill, Student | Mr. Hill has nothing to disclose. |
| Denis T. Balaban, MD (Massachusetts General Hospital) | Dr. Balaban has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Infucare. The institution of Dr. Balaban has received research support from ArgenX. |
| Kevin J. Kyle, MD (Massachusetts General Hospital) | Dr. Kyle has nothing to disclose. |
| Rebecca L. Gillani, MD (Massachusetts General Hospital) | The institution of Dr. Gillani has received research support from The Phyllis and Jerome Lyle Rappaport Foundation. The institution of Dr. Gillani has received research support from McCourt Foundation . The institution of Dr. Gillani has received research support from Roche. |
| Marcelo Matiello, MD, FAAN (Massachusetts General Hospital, Brigham, Harvard) | Dr. Matiello has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Matiello has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen. Dr. Matiello has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for WoltersKluwer. |
| Aleksandar Videnovic, MD, MSc, FAAN (MGH Neurological Clinical Research Institute) | Dr. Videnovic has nothing to disclose. |
| Eric Klawiter, MD, FAAN (Massachusetts General Hospital) | Dr. Klawiter has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Galen/Atlantica. Dr. Klawiter has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Klawiter has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Banner Life Sciences. Dr. Klawiter has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Greenwich Biosciences. Dr. Klawiter has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for OM1. Dr. Klawiter has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. The institution of Dr. Klawiter has received research support from Biogen. The institution of Dr. Klawiter has received research support from Abbvie. The institution of Dr. Klawiter has received research support from Genentech. |
| W. T. Kimberly, MD, PhD (Massachusetts General Hospital) | Dr. Kimberly has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astrocyte Pharmaceuticals. Dr. Kimberly has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Acasti Pharma. Dr. Kimberly has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Takeda. Dr. Kimberly has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Stryker. Dr. Kimberly has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurotherapeutics. Dr. Kimberly has stock in Woolsey Pharmaceuticals. Dr. Kimberly has stock in Acasti Pharma. The institution of Dr. Kimberly has received research support from NIH. The institution of Dr. Kimberly has received research support from Hyperfine, Inc.. The institution of Dr. Kimberly has received research support from Alzheimer's Association. Dr. Kimberly has received intellectual property interests from a discovery or technology relating to health care. |
| Farrah J. Mateen, MD, PhD, FAAN (Northwestern University Department of Neurology) | Dr. Mateen has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen. Dr. Mateen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Mateen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. The institution of Dr. Mateen has received research support from Genentech. The institution of Dr. Mateen has received research support from Amgen. The institution of Dr. Mateen has received research support from TG Therapeutics. Dr. Mateen has received intellectual property interests from a discovery or technology relating to health care. |